DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,447,266 | +15.2% | 301,101 | +0.7% | 0.01% | +20.0% |
| Q2 2023 | $3,861,309 | +30.4% | 298,863 | -1.0% | 0.01% | +25.0% |
| Q1 2023 | $2,961,390 | -4.0% | 301,874 | +4.1% | 0.00% | -20.0% |
| Q4 2022 | $3,084,562 | +1.7% | 289,903 | -0.2% | 0.01% | 0.0% |
| Q3 2022 | $3,033,000 | -20.5% | 290,504 | -4.1% | 0.01% | -16.7% |
| Q2 2022 | $3,813,000 | +12.5% | 302,865 | -3.1% | 0.01% | +20.0% |
| Q1 2022 | $3,389,000 | -26.4% | 312,634 | -4.4% | 0.01% | -16.7% |
| Q4 2021 | $4,603,000 | -23.5% | 327,134 | +4.5% | 0.01% | -33.3% |
| Q3 2021 | $6,015,000 | +232.9% | 313,112 | +70.7% | 0.01% | +200.0% |
| Q2 2021 | $1,807,000 | +0.5% | 183,448 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $1,798,000 | – | 182,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |